Benzinga | Feb 26, 2021 07:15AM EST

CIBC Upgrades Boralex to Outperformer, Lowers Price Target to $48

CIBC analyst Mark Javi upgrades Boralex (OTC:BRLXF) from Neutral to Outperformer and lowers the price target from $55 to $48.